Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice
about
Immunotherapy for tuberculosis: future prospectsLatently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis.The immunology of tuberculosis: from bench to bedside.A novel human IgA monoclonal antibody protects against tuberculosis.Advancing host-directed therapy for tuberculosis.Protective effect of a lipid-based preparation from Mycobacterium smegmatis in a murine model of progressive pulmonary tuberculosis.Vaccination with recombinant Mycobacterium tuberculosis PknD attenuates bacterial dissemination to the brain in guinea pigs.B cells regulate neutrophilia during Mycobacterium tuberculosis infection and BCG vaccination by modulating the interleukin-17 response.The use of anti-tuberculosis therapy for latent TB infectionThe role of B cells and humoral immunity in Mycobacterium tuberculosis infectionRole of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.The aerosol rabbit model of TB latency, reactivation and immune reconstitution inflammatory syndrome.Syndrome of selective IgM deficiency with severe T cell deficiency associated with disseminated cutaneous mycobacterium avium intracellulaire infection.Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine EfficacyB cells and antibodies in the defense against Mycobacterium tuberculosis infectionUpdate in tuberculosis 2005.Targeting Batf2 for infectious diseases and cancer.Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation.Immunological options for the treatment of tuberculosis: evaluation of novel therapeutic approaches.Immunogenicity of mycobacterial vesicles in humans: identification of a new tuberculosis antibody biomarker.Antibody-mediated immunity against tuberculosis: implications for vaccine developmentHow B cells shape the immune response against Mycobacterium tuberculosis.The protective role of antibody responses during Mycobacterium tuberculosis infection.Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis.Emerging trends in the formation and function of tuberculosis granulomas.Activated B cells in the granulomas of nonhuman primates infected with Mycobacterium tuberculosis.The protective effect of immunoglobulin in murine tuberculosis is dependent on IgG glycosylation.A pre-term infant of 32 weeks gestation with congenital tuberculosis treated successfully with antituberculosis chemotherapy.A significant therapeutic effect of immunoglobulins administered alone, or in combination with conventional chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains.Meta-analysis of human gene expression in response to Mycobacterium tuberculosis infection reveals potential therapeutic targets.Th1 cytokines, true functional signatures for protective immunity against TB?Adjunct antibody administration with standard treatment reduces relapse rates in a murine tuberculosis model of necrotic granulomas.
P2860
Q26741261-82F61A29-615E-4E57-966E-3C5D78A39007Q33719289-DD915750-7AD9-46F1-BDB5-50C94A4527A1Q33777367-BAC09033-8485-47E7-9E49-C4BE24FC9FD3Q33800841-D4B16567-C5E5-4A66-9162-4074088839BDQ34466861-4B198339-CC5E-4156-B36A-8D936E5A8C25Q34762605-9D8B4D1B-70E2-4BC6-ACB3-4E595FA13FC0Q34776544-B20AAFA6-E6A3-4CFD-8929-79620B443ED9Q34819635-3FA88B78-981C-4FFB-A96E-0A7EFA10F2FCQ35026573-9F281663-860D-4415-AC77-B06F7E3BB232Q35039807-A6721C9F-42E9-4EED-B92B-2DFCB7E03962Q35164284-7755BE09-058A-48FB-ABD5-3D300D9E5E66Q35769083-F6236AD4-80A6-4855-8073-C2B8BB992EDEQ36204984-9D2FF913-208D-4A25-B84C-62700E7F4319Q36219941-56548A9F-8339-450E-A81B-E68D71DF4E34Q36238031-1AB2DCDB-336F-4476-9D0A-D2065F3EAAEDQ36403165-46635DEC-A2FD-4774-A0EF-FCF856B92A41Q36413539-23E54B52-3532-4441-B6B0-8BE9CB7FF4F9Q36592223-EE0E462E-1834-4EF3-BF47-B01AEFAFB476Q36839739-D3D6D8DD-5DCA-4D3D-8382-00AF22FF4A92Q36927153-FE66822B-2E4E-45EB-9AF0-3C4B4A23DB51Q37137882-804AB6EF-B19A-42E8-ADBC-BF9CD1F2FA58Q37383963-41247F0C-07C8-4C8A-9C11-44646C1ECCB4Q37552026-BCC43915-7638-49EF-955C-7BBA475F2601Q39301694-69464ADE-F0EA-46D0-B841-4374431FDBE0Q39487696-67F07A59-C79C-446A-A871-2E0B5A4F31D2Q41879482-3515C56E-0F0C-4507-8507-9F65A76C1A37Q44900805-87DF6000-121B-429F-AD1F-A27451D58323Q48246165-11AB1CC4-987D-4A7A-AC43-17025031C4C2Q49549718-691F6FB3-2A1D-49DC-8FC2-568E6D463216Q49807763-D24F222A-BDE9-4CE3-890F-2C0E5C77870DQ49900955-AB266C1D-E59A-4C36-A7A7-7B530A600F6AQ55339701-310AF694-10AB-4540-8CA4-A9EB80B657DB
P2860
Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Therapeutic efficacy of high-d ...... tuberculosis infection in mice
@ast
Therapeutic efficacy of high-d ...... tuberculosis infection in mice
@en
Therapeutic efficacy of high-d ...... tuberculosis infection in mice
@nl
type
label
Therapeutic efficacy of high-d ...... tuberculosis infection in mice
@ast
Therapeutic efficacy of high-d ...... tuberculosis infection in mice
@en
Therapeutic efficacy of high-d ...... tuberculosis infection in mice
@nl
prefLabel
Therapeutic efficacy of high-d ...... tuberculosis infection in mice
@ast
Therapeutic efficacy of high-d ...... tuberculosis infection in mice
@en
Therapeutic efficacy of high-d ...... tuberculosis infection in mice
@nl
P2093
P2860
P1476
Therapeutic efficacy of high-d ...... tuberculosis infection in mice
@en
P2093
Barry Walker
Belinda Dagg
Douglas B Lowrie
Eleanor Roy
Elena Grigorieva
Evangelos Stavropoulos
John Brennan
M Joseph Colston
Ricardo E Tascon
Stephen Coade
P2860
P304
P356
10.1128/IAI.73.9.6101-6109.2005
P407
P577
2005-09-01T00:00:00Z